Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-small-cell Lung”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT06396065
What this trial is testing

Phase III Study of AK112 for NSCLC Patients

Who this might be right for
Non-Squamous Non-small Cell Lung Cancer
Summit Therapeutics 420
Testing effectiveness (Phase 2)Ended earlyNCT00549328
What this trial is testing

Monotherapy Pazopanib in Subjects With Advanced Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer, Non-Small Cell
GlaxoSmithKline 14
Not applicableLooking for participantsNCT02682667
What this trial is testing

Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols

Who this might be right for
Multiple MyelomaLymphoma, Non-HodgkinLeukemia-Lymphoma, Adult T-Cell+2 more
National Cancer Institute (NCI) 500
Testing effectiveness (Phase 2)Looking for participantsNCT06363734
What this trial is testing

Osimertinib Plus Dalpiciclib in Patients With EGFR-mutant, CDK4/6 Pathway Aberrant, Advanced Non-small Cell Lung Cancer Following Acquired Resistance to Third-generation EGFR TKI: a Phase II Trial

Who this might be right for
Non-small Cell Lung CancerEGFR Activating MutationCell Cycle Deregulation+1 more
Tianjin Medical University Cancer Institute and Hospital 32
Testing effectiveness (Phase 2)UnknownNCT04524299
What this trial is testing

Study of Radiotherapy Combined With Albumin Bound Paclitaxel and Nedaplatin for Locally Advanced NSCLC

Who this might be right for
Non-small Cell Lung Cancer
Sun Yat-sen University 160
Not applicableWithdrawnNCT01300299
What this trial is testing

STEREOtactic Radiation and Chemotherapy in Lung Cancer (STEREO)

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
University of Louisville
Testing effectiveness (Phase 2)Study completedNCT00092001
What this trial is testing

Study Of SU011248 In Patients With Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Pfizer 111
Testing effectiveness (Phase 2)UnknownNCT06182800
What this trial is testing

Adebrelimab Combined With Bevacizumab and Docetaxel for Advanced Non-Squamous Non-small Cell Lung Cancer After Progression on First-line Immunotherapy

Who this might be right for
Non-small Cell Lung Cancer
The First Affiliated Hospital of Xinxiang Medical College 35
Testing effectiveness (Phase 2)Study completedNCT05253807
What this trial is testing

Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Relapsed or Refractory Advanced Non-Small Cell Lung Cancer With an FGFR Alteration

Who this might be right for
Non-Small Cell Lung Cancer (NSCLC)
Incyte Corporation 8
Testing effectiveness (Phase 2)Study completedNCT00368992
What this trial is testing

S0536: Cetuximab, Paclitaxel, Carboplatin, and Bevacizumab in Treating Patients With Advanced Non-Small Cell Lung Cancer

Who this might be right for
Adenocarcinoma of the LungAdenosquamous Cell Lung CancerBronchoalveolar Cell Lung Cancer+5 more
National Cancer Institute (NCI) 110
Large-scale testing (Phase 3)Study completedNCT00982111
What this trial is testing

First-line Treatment of Patients With Stage IV Nonsquamous Non-Small Cell Lung Cancer With Necitumumab (IMC-11F8) and Pemetrexed-Cisplatin

Who this might be right for
Non Small Cell Lung Cancer
Eli Lilly and Company 633
Not applicableStudy completedNCT03725475
What this trial is testing

Reveal the Patient Characteristics and Treatment Patterns of Stage III Non-small-cell Lung Cancer Patients

Who this might be right for
Non-small-cell Lung Cancer (NSCLC)
AstraZeneca 3,111
Testing effectiveness (Phase 2)Study completedNCT00988936
What this trial is testing

Efficacy Study of [F-18]RGD-K5 Positron Emission Tomography (PET) as a Tool to Monitor Response to an Anti-angiogenic Drug

Who this might be right for
Metastatic Breast CancerMetastatic Colon/Rectum CancerNon-squamous Non-small Cell Lung Cancer
Siemens Molecular Imaging 35
Testing effectiveness (Phase 2)Looking for participantsNCT05498428
What this trial is testing

Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-small-Cell Lung
Janssen Research & Development, LLC 520
Testing effectiveness (Phase 2)Ended earlyNCT02335944
What this trial is testing

Study of Safety and Efficacy of EGFR-TKI EGF816 in Combination With cMET Inhibitor INC280 in Adult Patients With EGFR Mutated Non Small Cell Lung Cancer.

Who this might be right for
Non Small Cell Lung Cancer
Novartis Pharmaceuticals 177
Large-scale testing (Phase 3)Study completedNCT01631357
What this trial is testing

Study of Chemotherapy Combination With Autologous Cytokine-Induced Killer Cell Immunotherapy to Treat Lung Cancer

Who this might be right for
Non-small Cell Lung CancerSquamous Cell Carcinoma
Tianjin Medical University Cancer Institute and Hospital 96
Not applicableUnknownNCT04553601
What this trial is testing

Molecular Imaging Visualization of Tumor Heterogeneity in Non-small Cell Lung Cancer

Who this might be right for
NSCLCPET/CTBiopsy+3 more
The First Affiliated Hospital of Xiamen University 150
Early research (Phase 1)Not Yet RecruitingNCT07650357
What this trial is testing

CLSP 5282 in HLA-A*03:01 Positive Adult Patients With Solid Tumors (SENTINEL-101)

Who this might be right for
Advanced Solid TumorNon Small Cell Lung CancerPancreatic Carcinoma+1 more
Clasp Therapeutics, Inc. 140
Large-scale testing (Phase 3)Study completedNCT03856411
What this trial is testing

Evaluate the Efficacy and Safety of Toripalimab or Placebo Combined With Chemotherapy in Treatment-naive Advanced NSCLC

Who this might be right for
Treatment-naive Advanced Non-small Cell Lung Cancer
Shanghai Junshi Bioscience Co., Ltd. 465
Large-scale testing (Phase 3)Looking for participantsNCT06754644
What this trial is testing

Evaluate Efficacy, and Safety of QL2107 Plus Chemo and Compare With Keytruda in Participants With IV nqNSCLC

Who this might be right for
NSCLC
Qilu Pharmaceutical Co., Ltd. 808
Next Page